🕵️ Black Diamond Therapeutics, Inc. ($BDTX)
SEC insider & ownership activity, last 12 months · CIK 1701541 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| T. ROWE Price Investment Management, Inc. | 7.0% | 13G | Jul 8, 2026 | filing ↗ | |
| Blackrock, Inc. | 6.7% | 13G | Jul 27, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Shareholder vote (5.07) | Jun 26, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 21, 2026 | filing ↗ |
| Other events (8.01) | May 21, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 21, 2026 | filing ↗ |
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Earnings (2.02) | Mar 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 16, 2026 | filing ↗ |
| Earnings (2.02) | Dec 3, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 3, 2025 | filing ↗ |
| Other events (8.01) | Dec 3, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 3, 2025 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |
| Earnings (2.02) | Aug 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 7, 2025 | filing ↗ |